Best Clinical Trial Management Systems - Page 12

How Many Clinical Trial Management Systems Products Does G2 Track?

Total Products under this Category: 222

Category Stats (Nov 2026)

  • Average Rating: 4.27/5 (↑0.03 vs Oct 2026) The average rating of products in this category, based on all submitted ratings
  • Top Trending Product: TrialKit (+0.4%) - Among all products in this category, TrialKit recorded the largest rating increase compared to last month

Last updated: November 01, 2026

How Does G2 Rank Clinical Trial Management Systems Products?

Why You Can Trust G2's Software Rankings:

  • 30 Analysts and Data Experts
  • 900+ Authentic Reviews
  • 222+ Products
  • Unbiased Rankings

G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.

G2 Grid® for Clinical Trial Management Systems

G2 Grid® for Clinical Trial Management Systems plotting products by satisfaction and market presence

Highlighted products: OnCore CTMS, Viedoc, Clinical Research Suite, Florence eBinders, Rave CTMS, Clario CTMS, Vial EDC + eSource, and TrialKit.

Underlying data: [Grid® JSON](https://www.g2.com/categories/clinical-trial-management-systems/grids.json?focus%5B%5D=oncore-ctms&focus%5B%5D=viedoc&focus%5B%5D=clinical-research-suite&focus%5B%5D=florence-healthcare-florence-ebinders&focus%5B%5D=rave-ctms&focus%5B%5D=clario-ctms&focus%5B%5D=vial-edc-esource&focus%5B%5D=trialkit)

Prelude EDC

Prelude is the only R&D platform built exclusively for animal health and nutrition. Purpose-built for the complexity of animal studies, it gives sites and investigators the industry's most flexible, user-friendly EDC, and automates 90%+ of data management work. Founded in 2003, Prelude built one of the first eSource/EDC systems designed for complex studies without sacrificing a clean, simple experience for sites and investigators. Today it's a full eClinical platform includes: EDC, ePRO, eConsent, RTSM, and medical coding. Prelude is trusted globally by leading institutions including Cornell, Johns Hopkins, Merck, and Boehringer Ingelheim. What sets Prelude apart is partnership: fully in-house support and a configurable platform, with Customer Success Managers who work as an extension of your team through build and beyond.

Average Rating: 4.9/5.0

Total Reviews: 21

How Do G2 Users Rate Prelude EDC?

  • Quality of Support: 9.9/10 (Category avg: 8.6/10)

Who Is the Company Behind Prelude EDC?

  • Seller: Prelude
  • Year Founded: 2003
  • HQ Location: Austin, TX
  • LinkedIn® Page: www.linkedin.com
    52 employees on LinkedIn®

Who Uses This Product?

  • Top Industries: Research, Veterinary
  • Company Size: 57% Small, 33% Medium

What Are Recent G2 Reviews of Prelude EDC?

Protocol Manager

Protocol Manager helps clinical operations manage global trials of drugs, devices, biologics, and vaccines in all phases of development.

Who Is the Company Behind Protocol Manager?

QMENTA Neuroimaging Platform

QMENTA is the AI orchestration platform for regulated medical imaging in clinical trials and research. Designed specifically for imaging-intensive multi-site studies, the platform connects scanners, sites, AI models, and regulators into a single auditable system — compressing trial timelines and eliminating operational imaging risk.The platform covers the complete imaging workflow: cloud-based site activation with no IT setup, real-time QC and protocol adherence monitoring, vendor-neutral harmonisation across scanner manufacturers, governed AI deployment with version-locked and audit-trailed algorithms, zero-footprint central review for all stakeholders, and automated regulatory closeout documentation. The full chain of custody from first scan to submission lives in one system.QMENTA is 510(k)-cleared by the FDA, compliant with FDA 21 CFR Part 11, HIPAA, GDPR, ISO 13485, and GxP standards, and has achieved zero nonconformities across all external pharmaceutical partner audits. The platform supports more than 90 validated imaging AI workflows and biomarker tools, is vendor-neutral across GE HealthCare, Siemens Healthineers, Philips, Canon, and any DICOM system, and is deployable on GCP, AWS, or Azure.QMENTA is in production across more than 400 imaging sites, with over 16 million imaging files processed and 1.3 million subjects across clinical trials, academic medical centres, and biopharma programmes. Customers include Cleveland Clinic, Cedars-Sinai, Harvard Medical School, UCSF, Bayer, ICON, and Parexel. The platform served as the operational backbone for the CAVS-MS trial, which validated Central Vein Sign biomarkers and contributed to revising the McDonald Criteria — the global diagnostic standard for Multiple Sclerosis.

Average Rating: 5.0/5.0

Total Reviews: 1

Who Is the Company Behind QMENTA Neuroimaging Platform?

  • Seller: QMENTA
  • Year Founded: 2013
  • HQ Location: Boston, US
  • LinkedIn® Page: www.linkedin.com
    37 employees on LinkedIn®

Who Uses This Product?

  • Company Size: 100% Small

What Are Recent G2 Reviews of QMENTA Neuroimaging Platform?

AI can help you find the answers. G2 helps you trust them.

Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.

How it works

Quanthealth

QuantHealth is an AI-driven healthcare company revolutionizing drug development through advanced clinical trial simulations. Founded in 2020, the company has successfully simulated over 350 clinical trials with an impressive 85% accuracy rate. Its cutting-edge in-silico platform enables pharmaceutical and biotechnology companies to accelerate and de-risk their development processes, bringing more effective treatments to patients faster and more affordably. Key Features and Functionality: - Comprehensive Data Integration: Utilizes a proprietary knowledge graph with over 5 million data points, mapping the full biological cascade from therapeutic entities to diseases. - Rich Patient Data: Accesses a database of 350 million patient lives, each with over 10,000 data points spanning more than a decade, enabling nuanced modeling of patient sub-populations. - Virtual Clinical Trials: Simulates diverse, real-world patient responses to investigational therapies, closely approximating actual clinical outcomes. - Protocol Design and Optimization: Allows trial design teams to modify protocol parameters and assess their clinical, operational, and commercial impacts, optimizing inclusion/exclusion criteria and treatment combinations. - Indication Selection: Predicts drug efficacy and safety across various medical conditions, facilitating precise decision-making in early clinical development. - Portfolio Management: Enables nuanced modeling and predictions for planned and ongoing studies, assisting in asset prioritization and identifying strategic gaps and opportunities. Primary Value and Problem Solved: QuantHealth addresses the high failure rates and substantial costs associated with traditional clinical trials by providing a platform that predicts patient responses to therapies with high accuracy. This capability allows pharmaceutical companies to design more effective trials, select appropriate indications, and optimize portfolios, ultimately accelerating the development of groundbreaking therapies and reducing time-to-market. By generating synthetic evidence across all clinical phases, QuantHealth is shaping the future of healthcare, making treatments more accessible and affordable for patients worldwide.

Who Is the Company Behind Quanthealth?

QuesGen EDC

A web-based solution that can be used for recruiting patients and managing all aspects of data associated with clinical research.

Average Rating: 4.5/5.0

Total Reviews: 1

How Do G2 Users Rate QuesGen EDC?

  • Quality of Support: 8.3/10 (Category avg: 8.6/10)

Who Is the Company Behind QuesGen EDC?

Who Uses This Product?

  • Company Size: 100% Large

What Are Recent G2 Reviews of QuesGen EDC?

RealTime-Devana

RealTime-Devana is a holistic business intelligence platform designed specifically for research site organizations, driving transparency and accountability across all functional groups. From pipeline management and streamlined study start-up through to historical trial metrics, Devana provides one source of truth for all your clinical trial data and processes. Improve turnaround times and stand out to CROs and sponsors with Devana’s powerful workflow improvements and data analytics.

Who Is the Company Behind RealTime-Devana?

Ryght AI

Ryght AI develops an enterprise-scale generative AI platform and applications to accelerate clinical trials.

Who Is the Company Behind Ryght AI?

  • Seller: Ryght AI
  • Year Founded: 2023
  • HQ Location: Laguna Beach, US
  • LinkedIn® Page: www.linkedin.com
    23 employees on LinkedIn®

SCIENOPS Drug Develop AI

SCIENOPS Drug Develop AI is an advanced platform designed to revolutionize the drug development process by integrating artificial intelligence (AI) into clinical trials and regulatory workflows. By leveraging AI-driven solutions, SCIENOPS aims to accelerate patient recruitment, enhance protocol adherence, and reduce the overall costs and time associated with bringing new therapies to market. Key Features and Functionality: - AI in Clinical Trials: Utilizes Bayesian adaptive trials, AI-powered patient matching, and real-world evidence (RWE) to optimize trial design and execution. - AI-Powered Document Intelligence: Extracts and synthesizes data from regulatory submissions, feasibility studies, and adverse event reports to streamline documentation processes. - Federated Compliance Tracking: Maintains audit trails, monitors compliance risks, and ensures inspection readiness through AI-driven monitoring systems. - Retrieval-Augmented Generation (RAG) for Decision-Making: Synthesizes trial insights to facilitate risk-based monitoring and adaptive trial adjustments. - AI-Driven Enrollment & Trial Optimization: Automates patient-trial matching using electronic health records (EHRs), ICD-10 codes, and prescription data; employs predictive analytics for faster patient selection; and ensures diverse and representative trial populations through machine learning. Primary Value and Solutions Provided: SCIENOPS Drug Develop AI addresses the inherent challenges in clinical trials, such as high costs, lengthy timelines, and regulatory complexities. By automating and optimizing various aspects of the trial process, the platform enhances efficiency, reduces errors, and accelerates the development of new drugs. This leads to faster approvals, minimized regulatory bottlenecks, and ultimately, quicker delivery of effective therapies to patients in need.

Who Is the Company Behind SCIENOPS Drug Develop AI?

Scienta Lab

Scienta Lab is an AI-powered platform pioneering Precision Immunology

Who Is the Company Behind Scienta Lab?

SimpleCTMS

SimpleTrials is a Clinical Trial Management System for Sponsors, CROs and Sites. SimpleCTMS was designed and developed to offer the benefits of a CTMS (Clinical Trial Management System) without the extensive upfront financial and resource commitments associated with traditional enterprise systems or the inherent inefficiencies of worksheet trackers.

Who Is the Company Behind SimpleCTMS?

SimpleTrials CTMS

SimpleTrials is the industry’s first on-demand, subscription-based CTMS for sites, vendors and sponsors. SimpleTrials CTMS provides the robust functionality needed to manage the most complex studies with the ease of use that busy teams require.

Who Is the Company Behind SimpleTrials CTMS?

Emma Stein
ES
Researched and written by Emma Stein
Updated October 3, 2024